✦ LIBER ✦

Phosphodiesterase Type 5 Inhibitors as Adjunctive Therapy in the Management of Systolic Heart Failure

✍ Scribed by Cvelich, R. G.; Roberts, S. C.; Brown, J. N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitors of cyclic nucleotide phosphod

✍ Stehlik, Josef; Movsesian, Matthew A 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 208 KB

Utilisation of Optimal Medical Therapy i

✍ M. Liang; J. Mazhar; G. Devlin; M. Stiles 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Utilisation of Optimal Medical Therapy i

✍ J Mazhar; M Liang; G Devlin; MK Stiles 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Adjunctive Therapy and Management of the

✍ Feitell, Scott; Hankins, Shelley R.; Eisen, Howard J. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 284 KB

Potential Role of Type 5 Phosphodiestera

✍ Stuart D. Katz 📂 Article 📅 2003 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 730 KB

Italian multicenter study on the safety

✍ E. Baggio; R. Gandini; A.C. Plancher; M. Passeri; G. Carmosino 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 412 KB